2002
DOI: 10.1002/jms.333
|View full text |Cite
|
Sign up to set email alerts
|

Mass spectrometry of cis‐diamminedichloroplatinum(II) adducts with the dinucleosidemonophosphates d(ApG), d(GpG) and d(TpC) in an ion trap

Abstract: The detection and fragmentation behaviour of adducts of the chemotherapeutic cis-diamminedichloroplatinum(II) (cisplatin) with the dinucleosidemonophosphates d(ApG), d(GpG) and d(TpC) as model compounds for DNA adducts in an ion trap with electrospray ionization were studied. Mainly the monofunctional adduct, the bifunctional adduct and the bifunctional adduct with platinum bridging two dinucleosidemonophosphates were detected. In addition, several more complex adducts were seen resulting from reactions among … Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

1
24
0

Year Published

2002
2002
2018
2018

Publication Types

Select...
7

Relationship

0
7

Authors

Journals

citations
Cited by 32 publications
(25 citation statements)
references
References 23 publications
1
24
0
Order By: Relevance
“…The investigations of even longer oligomers showed d(ApGpGpT)‐Pt(DACH) as the most abundant one supporting the findings at dimer and trimer level (GG and GGT are the major formed adducts). The fragmentation of the oxaliplatin tetranucleotide adducts in the ion trap is similar to cisplatin adducts, but the fragments indicate that the oxaliplatin complexation is rather flexible and less stable in gas phase allowing rearrangements of the complexes. We observe a new gas phase interbase rearrangement (fragmentation pathways FB, FH and FI).…”
Section: Resultsmentioning
confidence: 92%
See 1 more Smart Citation
“…The investigations of even longer oligomers showed d(ApGpGpT)‐Pt(DACH) as the most abundant one supporting the findings at dimer and trimer level (GG and GGT are the major formed adducts). The fragmentation of the oxaliplatin tetranucleotide adducts in the ion trap is similar to cisplatin adducts, but the fragments indicate that the oxaliplatin complexation is rather flexible and less stable in gas phase allowing rearrangements of the complexes. We observe a new gas phase interbase rearrangement (fragmentation pathways FB, FH and FI).…”
Section: Resultsmentioning
confidence: 92%
“…In most cases, the 5’ base is the adducted base, but a few exceptions exist. The most abundant adduct at the ICL dinucleotide level is the d(pGpC)‐Pt(DACH)‐d(pGpC), comparable to cisplatin‐DNA adducts . Adducts with modifications at the same ends of both DNA strands represented 85% of the total interstrand cross‐linked complexes with a distribution of G‐Pt‐G (0.56) to A‐Pt‐G (0.44).…”
Section: Resultsmentioning
confidence: 99%
“…In medicine, metal ions find broad therapeutic application on DNA, as cisplatin complexes and related drugs form DNA-adducts, which act as toxic agents in tumor tissue [6]. These drugs are widely applied even though the mechanism on the molecular level is not fully elucidated yet [7]. Furthermore, there are approaches to use metal ions as markers for improved diagnostic applications [8 -14].…”
mentioning
confidence: 99%
“…Again the structure analysis of the modified oligonucleotides was based on ESI/MSMS data, but quantitative data were only accessible via LC/ICP‐MS . In this study we used phosphorus again to quantify DNA adducts in order to show DNA repair of cross links (Figure )…”
Section: Applicationsmentioning
confidence: 99%